These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


237 related items for PubMed ID: 17714751

  • 1. Delayed and persistent ERK1/2 activation is required for 4-hydroxytamoxifen-induced cell death.
    Zhou JH, Yu DV, Cheng J, Shapiro DJ.
    Steroids; 2007 Oct; 72(11-12):765-77. PubMed ID: 17714751
    [Abstract] [Full Text] [Related]

  • 2. Estrogen receptor-dependent and estrogen receptor-independent pathways for tamoxifen and 4-hydroxytamoxifen-induced programmed cell death.
    Obrero M, Yu DV, Shapiro DJ.
    J Biol Chem; 2002 Nov 22; 277(47):45695-703. PubMed ID: 12244117
    [Abstract] [Full Text] [Related]

  • 3. Activation of the p38 mitogen-activated protein kinase pathway by estrogen or by 4-hydroxytamoxifen is coupled to estrogen receptor-induced apoptosis.
    Zhang CC, Shapiro DJ.
    J Biol Chem; 2000 Jan 07; 275(1):479-86. PubMed ID: 10617642
    [Abstract] [Full Text] [Related]

  • 4. Effect of prolonged hydroxytamoxifen treatment of MCF-7 cells on mitogen activated kinase cascade.
    Rabenoelina F, Semlali A, Duchesne MJ, Freiss G, Pons M, Badia E.
    Int J Cancer; 2002 Apr 10; 98(5):698-706. PubMed ID: 11920638
    [Abstract] [Full Text] [Related]

  • 5. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
    Zhang YX, Kong CZ.
    Zhonghua Yi Xue Za Zhi; 2008 Jan 22; 88(4):271-5. PubMed ID: 18361842
    [Abstract] [Full Text] [Related]

  • 6. Tamoxifen-induced rapid death of MCF-7 breast cancer cells is mediated via extracellularly signal-regulated kinase signaling and can be abrogated by estrogen.
    Zheng A, Kallio A, Härkönen P.
    Endocrinology; 2007 Jun 22; 148(6):2764-77. PubMed ID: 17363451
    [Abstract] [Full Text] [Related]

  • 7. Opposing effects of ERK and p38 MAP kinases on HeLa cell apoptosis induced by dipyrithione.
    Fan Y, Chen H, Qiao B, Luo L, Ma H, Li H, Jiang J, Niu D, Yin Z.
    Mol Cells; 2007 Feb 28; 23(1):30-8. PubMed ID: 17464209
    [Abstract] [Full Text] [Related]

  • 8. The conditional kinase DeltaMEKK1:ER* selectively activates the JNK pathway and protects against serum withdrawal-induced cell death.
    Molton SA, Weston C, Balmanno K, Newson C, Todd DE, Garner AP, Cook SJ.
    Cell Signal; 2005 Nov 28; 17(11):1412-22. PubMed ID: 15893455
    [Abstract] [Full Text] [Related]

  • 9. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
    Tyagi A, Agarwal R, Agarwal C.
    Oncogene; 2003 Mar 06; 22(9):1302-16. PubMed ID: 12618755
    [Abstract] [Full Text] [Related]

  • 10. Estrogen attenuates lipopolysaccharide-induced nitric oxide production in macrophages partially via the nongenomic pathway.
    Liu L, Wang Z.
    Cell Immunol; 2013 Mar 06; 286(1-2):53-8. PubMed ID: 24321566
    [Abstract] [Full Text] [Related]

  • 11. Resveratrol Inhibits the Epidermal Growth Factor-Induced Migration of Osteoblasts: the Suppression of SAPK/JNK and Akt.
    Kawabata T, Tokuda H, Fujita K, Kainuma S, Sakai G, Matsushima-Nishiwaki R, Kozawa O, Otsuka T.
    Cell Physiol Biochem; 2017 Mar 06; 43(3):1025-1036. PubMed ID: 28968596
    [Abstract] [Full Text] [Related]

  • 12. Raloxifene analogue LY117018 suppresses oxidative stress-induced endothelial cell apoptosis through activation of ERK1/2 signaling pathway.
    Yu J, Eto M, Kozaki K, Akishita M, Okabe T, Ouchi Y.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):32-6. PubMed ID: 18541231
    [Abstract] [Full Text] [Related]

  • 13. Low concentrations of nitric oxide (NO) induced cell death in PC12 cells through activation of p38 mitogen-activated protein kinase (p38 MAPK) but not via extracellular signal-regulated kinases (ERK1/2) or c-Jun N-terminal protein kinase (JNK).
    Yamamoto T, Yuyama K, Yamamoto H.
    Neurosci Lett; 2006 Jan 16; 392(3):170-3. PubMed ID: 16198052
    [Abstract] [Full Text] [Related]

  • 14. MEKK1 activation of human estrogen receptor alpha and stimulation of the agonistic activity of 4-hydroxytamoxifen in endometrial and ovarian cancer cells.
    Lee H, Jiang F, Wang Q, Nicosia SV, Yang J, Su B, Bai W.
    Mol Endocrinol; 2000 Nov 16; 14(11):1882-96. PubMed ID: 11075819
    [Abstract] [Full Text] [Related]

  • 15. Involvement of histone H3 phosphorylation through p38 MAPK pathway activation in casticin-induced cytocidal effects against the human promyelocytic cell line HL-60.
    Kikuchi H, Yuan B, Yuhara E, Takagi N, Toyoda H.
    Int J Oncol; 2013 Dec 16; 43(6):2046-56. PubMed ID: 24064676
    [Abstract] [Full Text] [Related]

  • 16. The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells.
    Vivacqua A, Bonofiglio D, Recchia AG, Musti AM, Picard D, Andò S, Maggiolini M.
    Mol Endocrinol; 2006 Mar 16; 20(3):631-46. PubMed ID: 16239258
    [Abstract] [Full Text] [Related]

  • 17. The inhibition of ERK activation mediates the protection of necrostatin-1 on glutamate toxicity in HT-22 cells.
    Zhang M, Li J, Geng R, Ge W, Zhou Y, Zhang C, Cheng Y, Geng D.
    Neurotox Res; 2013 Jul 16; 24(1):64-70. PubMed ID: 23307752
    [Abstract] [Full Text] [Related]

  • 18. Palmitic acid promotes endothelial progenitor cells apoptosis via p38 and JNK mitogen-activated protein kinase pathways.
    Jiang H, Liang C, Liu X, Jiang Q, He Z, Wu J, Pan X, Ren Y, Fan M, Li M, Wu Z.
    Atherosclerosis; 2010 May 16; 210(1):71-7. PubMed ID: 20226460
    [Abstract] [Full Text] [Related]

  • 19. c-Jun activation is required for 4-hydroxytamoxifen-induced cell death in breast cancer cells.
    Madeo A, Vinciguerra M, Lappano R, Galgani M, Gasperi-Campani A, Maggiolini M, Musti AM.
    Oncogene; 2010 Feb 18; 29(7):978-91. PubMed ID: 19935718
    [Abstract] [Full Text] [Related]

  • 20. Mitogen-activated protein kinase mediates mevalonate-stimulated human mesangial cell proliferation.
    Zhou X, Wang C, Tian J, Wang Y, Li Y, Hu Z, Li R.
    Mol Med Rep; 2015 Aug 18; 12(2):2643-9. PubMed ID: 25936991
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.